Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CVKD Stock Alerts

Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History

Cadrenal Therapeutics logo
$1.80 -0.06 (-2.96%)
As of 02:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Cadrenal Therapeutics Stock Price Performance

The Cadrenal Therapeutics (CVKD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.03%, with a year-to-date return of -73.38%. In the past month, the stock has decreased 25.41%, reflecting recent market activity.

As of the latest close, Cadrenal Therapeutics traded at $1.86 with a market cap of $6.36 million and volume of 35,859 shares.

Receive CVKD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-7.44%
1 Month
Performance
-25.41%
3 Month
Performance
-65.75%
Year-To-Date
Performance
-73.38%
1 Year
Performance
-86.03%

CVKD Stock Chart for Friday, August, 14, 2026

CVKD Chart by TradingView

Cadrenal Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/13/2026$1.84$1.86
+1.09%		$1.97$1.7635,859 shs$6.36 million
08/12/2026$1.94$1.84
-5.15%		$1.98$1.7763,640 shs$6.29 million
08/11/2026$1.94$1.94$2.12$1.9246,330 shs$6.64 million
08/10/2026$1.95$1.94
-0.51%		$2.01$1.9119,978 shs$6.63 million
08/07/2026$1.87$1.95
+4.28%		$2.05$1.8730,080 shs$6.66 million
08/06/2026$1.96$1.87
-4.59%		$1.99$1.8725,716 shs$6.40 million
08/05/2026$2.03$1.96
-3.45%		$2.10$1.9033,044 shs$6.70 million
08/04/2026$1.96$2.03
+3.57%		$2.17$1.9640,673 shs$6.94 million
08/03/2026$2.01$1.96
-2.49%		$2.16$1.9040,915 shs$6.70 million
07/31/2026$2.09$2.01
-3.83%		$2.11$1.9714,929 shs$6.87 million
07/30/2026$1.99$2.09
+5.08%		$2.09$1.9617,769 shs$7.15 million
07/29/2026$2.01$1.99
-1.04%		$2.05$1.9613,369 shs$6.80 million
07/28/2026$2.06$2.01
-2.43%		$2.10$1.9832,483 shs$6.87 million
07/27/2026$2.04$2.06
+0.98%		$2.14$1.9571,099 shs$7.05 million
07/24/2026$2.03$2.04
+0.49%		$2.16$1.9280,136 shs$6.32 million
07/23/2026$2.10$2.03
-3.33%		$2.13$1.8659,699 shs$6.29 million
07/22/2026$2.17$2.10
-3.23%		$2.24$2.0539,347 shs$6.51 million
07/21/2026$2.09$2.17
+3.83%		$2.39$2.10167,984 shs$6.73 million
07/20/2026$2.16$2.09
-3.24%		$2.26$2.0730,801 shs$6.48 million
07/17/2026$2.33$2.16
-7.30%		$2.36$2.1346,552 shs$6.70 million
07/16/2026$2.35$2.33
-0.85%		$2.57$2.3085,962 shs$7.22 million
07/15/2026$2.42$2.35
-2.89%		$2.67$2.3153,366 shs$6.74 million
07/14/2026$2.42$2.42$2.42$2.2949,334 shs$6.95 million
07/13/2026$2.89$2.42
-16.26%		$3.17$2.34276,983 shs$6.94 million
Related Companies

This page (NASDAQ:CVKD) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Why I'm sending this one to my own family
Behind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...
Behind the Markets | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Why November 27 Is Quickly Becoming America's Most Important Financial Date in Decades
An estimated $10 trillion could move through a little known government initiative, according to analyst Joel L...
Altimetry | Sponsoredtc pixel
Leading AI Insider Issues Urgent Market Warning
A leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...
TradeSmith | Sponsoredtc pixel